Patents by Inventor Erik Andersen

Erik Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6542977
    Abstract: A method and apparatus for combining cost effectiveness of data signal ports sharing a common memory storage device with reliable data signal communication of data signal ports each having a dedicated memory storage device. In one embodiment, data signals are received at a number of data signal ports of a data signal communication platform. A data signal bandwidth capability of a memory storage device of the data communication platform is determined. Once the data signal bandwidth capability of the memory storage device is determined, the memory storage device is segmented to improve utilization of the data signal bandwidth capability. As a result, cost effectiveness of data signal ports sharing a common memory storage device and reliability of data signal communication of data signal ports each having a dedicated memory storage device is combined.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: April 1, 2003
    Assignee: Intel Corporation
    Inventor: Erik Andersen
  • Patent number: 6511474
    Abstract: The present invention is a bolus for an enteral feeding tube, or catheter, that is capable of being used in an over-the-wire intubation procedure as well as other intubation procedures. The bolus has a generally tubular body defining a sidewall, a proximal end tube opening capable of being connected to a distal end of the enteral feeding tube, and a generally rounded terminal end having a flattened tip. The bolus includes a fluid opening within the sidewall of the bolus between the proximal end opening and the terminal end of the bolus. An interior surface of the sidewall opposite the fluid opening is curved and slopes upwardly toward a distal end of the fluid opening. The curved interior surface and the fluid opening configuration allows for fluid flow that approximates the fluid flow rate characteristics of an open-ended tube. The fluid opening is biased toward the terminal end of the bolus thereby defining an elongated collar portion adjacent the proximal end tube opening of the bolus.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: January 28, 2003
    Assignee: Corpak, Inc.
    Inventor: Erik Andersen
  • Patent number: 6505654
    Abstract: A stent for reinforcement of the lumen of a peristaltic organ is formed by knitting preferably a nitinol wire into a pattern of overlapping loops selected such that from a relaxed state each row of loops may shift axially relative to and independently of the rows on either side. This local lengthening and shortening accommodate peristalsis of the organ without migrating within the organ. A stent is also shown which comprises two resilient cylindrical mesh layers and a semi-permeable compliant membrane such as expanded polytetrafluoroethylene, sandwiched between. The two mesh layers may be knit of a flexible filament, and the knit may be configured so that the stent can adapt to peristalsis of the body lumen. A method is also shown of manufacturing a delivery system for a resilient tubular device such as a stent so that the device can be inserted into the body in a substantially reduced diameter. The method uses a confining block having a bore and a slot leading into the bore.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: January 14, 2003
    Assignee: Scimed Life Systems, Inc.
    Inventors: Erik Andersen, Ernst Peter Strecker
  • Patent number: 6482170
    Abstract: A gastric pressure relief apparatus for incorporation within an enteral feeding system, including an enteral feeding container, an administrative tube and an enteral feeding tube. The apparatus comprises a gas and liquid-receiving reservoir with a gas vent to ambient atmosphere, a length of tube secured to the reservoir at one end and joined to the enteral feeding tube at another end and connector means for joining the administrative tube to the length of tube to be oriented at a point below that of an enterally-fed patient's stomach. The length of tube includes volumetric indicia to allow for measurement of refluxed fluid and subsequent adjustment of fluid administration.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: November 19, 2002
    Assignee: Corpak, Inc.
    Inventor: Erik Andersen
  • Publication number: 20020151539
    Abstract: The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula 1
    Type: Application
    Filed: March 14, 2002
    Publication date: October 17, 2002
    Inventors: Tine Krogh Jorgensen, Knud Erik Andersen, Rolf Hohlweg, Uffe Bang Olsen, Erik Fischer, Zdenek Polivka, Kaler Sindelar
  • Patent number: 6463837
    Abstract: A guiding device for a rotatable, circular saw blade of a house-building saw. Such a saw comprises a bench-shaped stand (2) with a frame (98) which is movable therein and on which the saw blade (12) is rotatably mounted, and an operating mechanism (26) for raising and lowering the frame (98) in the stand (2). According to the invention the guiding device comprises guide elements (90, 92) whereby the frame (98) can also be moved along the bench surface (4) after the frame (98) has been moved to near an upper position.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: October 15, 2002
    Assignee: Emex As
    Inventors: Tom Erik Andersen, Jan Hansen
  • Patent number: 6437147
    Abstract: A novel class of imidazo heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment and/or prevention of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: August 20, 2002
    Assignees: Novo Nordisk, Boehringer Ingelheim International GmbH
    Inventors: Knud Erik Andersen, Florencio Zaragoza Dorwald, Bernd Peschke, Ulla Grove Sidelmann, Klaus Rudolf, Dirk Stenkamp, Rudolf Hurnaus, Stephan Georg Muller, Bernd Krist, Birgitte Eriksen
  • Publication number: 20020091981
    Abstract: Hardware for communicating between at least two circuits via a serial communication link. The two circuits have interfaces for receiving or transmitting data cells. The hardware supports a first in first out (FIFO) protocol.
    Type: Application
    Filed: January 9, 2001
    Publication date: July 11, 2002
    Inventors: Erik Andersen, Jens C. Michelsen
  • Patent number: 6417218
    Abstract: A class of substituted imidazole compounds of formula I methods for their preparation, pharmaceutical compositions comprising them and use thereof in the treatment of disorders related to the histamine H3 receptor are disclosed. More particularly, these compounds possess histamine H3 receptor antagonistic activity and are thus useful for the treatment of disorders in which a histamine H3 receptor blockade is beneficial.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: July 9, 2002
    Assignees: Novo Nordisk A/S, Boehringer Ingelheim International GmbH
    Inventors: Florencio Zaragoza Dorwald, Knud Erik Andersen
  • Patent number: 6391890
    Abstract: The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula wherein X, Y, Z, R1, R2 and m are as defined in the detailed part of the present description, or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation, as well as their use for treatment of indications caused by or related to the secretion and circulation of insulin antagonising peptides, e.g. non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: May 21, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Tine Krogh Jørgensen, Knud Erik Andersen, Rolf Hohlweg, Uffe Bang Olsen, Erik Fischer, Zdenek Polivka, Kaler Sindelar
  • Publication number: 20020058659
    Abstract: A novel class of imidazo heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment and/or prevention of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.
    Type: Application
    Filed: March 16, 2001
    Publication date: May 16, 2002
    Inventors: Knud Erik Andersen, Florencio Zaragiza Dorwald, Bernd Peschke, Ulla Grove Sidelmann, Klaus Rudolf, Dirk Stenkamp, Rudolf Hurnaus, Stephan Georg Muller, Bernd Krist, Birgitte Eriksen
  • Publication number: 20020033085
    Abstract: A guiding device for a rotatable, circular saw blade of a house-building saw. Such a saw comprises a bench-shaped stand (2) with a frame (98) which is movable therein and on which the saw blade (12) is rotatably mounted, and an operating mechanism (26) for raising and lowering the frame (98) in the stand (2). According to the invention the guiding device comprises guide elements (90, 92) whereby the frame (98) can also be moved along the bench surface (4) after the frame (98) has been moved to near an upper position.
    Type: Application
    Filed: August 13, 1999
    Publication date: March 21, 2002
    Inventors: TOM ERIK ANDERSEN, JAN HANSEN
  • Patent number: 6355070
    Abstract: A stent for reinforcement of the lumen of a peristaltic organ is formed by knitting preferably a nitinol wire into a pattern of overlapping loops selected such that from a relaxed state each row of loops may shift axially relative to and independently of the rows on either side. This local lengthening and shortening accommodate peristalsis of the organ without migrating within the organ. A stent is also shown which comprises two resilient cylindrical mesh layers and a semi-permeable compliant membrane such as expanded polytetrafluoroethylene, sandwiched between. The two mesh layers may be knit of a flexible filament, and the knit may be configured so that the stent can adapt to peristalsis of the body lumen. A method is also shown of manufacturing a delivery system for a resilient tubular device such as a stent so that the device can be inserted into the body in a substantially reduced diameter. The method uses a confining block having a bore and a slot leading into the bore.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: March 12, 2002
    Assignee: Scimed Life Systems, Inc.
    Inventors: Erik Andersen, Ernst Peter Strecker
  • Publication number: 20010049385
    Abstract: A novel class of imidazo heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment and/or prevention of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.
    Type: Application
    Filed: March 16, 2001
    Publication date: December 6, 2001
    Inventors: Knud Erik Andersen, Florencio Zaragoza Dorwald, Bernd Peschke
  • Patent number: 6305436
    Abstract: Methods for forming, shaping and heat treating stents for reinforcement of the lumen of peristaltic organs. The stent is formed by knitting preferably a nitinol wire into a pattern of overlapping loops selected such that from a relaxed state each row of loops may shift axially relative to and independently of the rows on either side. This local lengthening and shortening accommodates peristalsis of the organ without migrating within the organ.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: October 23, 2001
    Assignee: Scimed Life Systems, Inc.
    Inventors: Erik Andersen, Ernst Peter Strecker, Kathleen L. Hess, Susanne Urhoj
  • Publication number: 20010004696
    Abstract: This invention provides prosthesis delivery systems with tips constructed to permit both easier advance into the body and easier removal from the body after expanding the prosthesis. The tip includes a distal taper that can gently widen a lumen during advance in instances where the lumen is narrower than the tip and a proximal taper that can gently widen the lumen on retraction in instances where the prosthesis does not immediately expand the lumen to provide clearance for the larger diameter tip.
    Type: Application
    Filed: October 20, 1998
    Publication date: June 21, 2001
    Applicant: BOSTON SCIENTIFIC CORPORATION
    Inventors: GEORGE T. ROBERTS, ERIK ANDERSEN
  • Patent number: 6239148
    Abstract: The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: May 29, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Florenzio Zaragossa Dörwald, Knud Erik Andersen, Rolf Hohlweg, Peter Madsen, Tine Krogh Jørgensen, Uffe Bang Olsen, Henrik Sune Andersen, Svend Treppendahl, Polivka Zdenék, Silhánková Alexandra, Sindelár Karel
  • Patent number: 6221099
    Abstract: A tubular prosthesis including a tubular wall portion of loosely interlocked pattern, e.g. of knitted loops, constructed to function within a body lumen. The loops are preferably formed of co-knitted strand materials. A first strand material is a metal strand that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen. A second strand material is a predetermined substance selected to provide desired characteristics to the wall of the prosthesis.
    Type: Grant
    Filed: February 7, 1997
    Date of Patent: April 24, 2001
    Assignee: Boston Scientific Corporation
    Inventors: Erik Andersen, Ernst Peter Strecker
  • Patent number: 6214816
    Abstract: The compounds are N-substituted azaheterocyclic compounds of formula I wherein R1 and R2 independently are hydrogen, halogen, trifluoromethyl, hydroxy, C1-6-alkyl or C1-6-alkoxy; and Y is >N—CH2— wherein only the underscored atom participates in the ring system; and X is —C(R6R7)—, —CH2CH2—, —CH═CH—CH2—, —CH2—CH═CH—, —CH2—(C═O)—, —(C═O)—CH2—, —CH2CH2CH2—, —CH═CH—, CH(R10)CH2—, —CH2CH(R10) or —(C═O)— wherein R6 and R7 independently are hydrogen or C1-6-alkyl and wherein R10 is C1-6-alkyl or phenyl; and r is 0, 1 or 2; and Z is selected from wherein A is —CH2—, —O—, —S— or —N(R5)— wherein R5 is H or C1-6-alkyl; and R3 is —(CH2)pCOR4 wherein p is 1, 2, 3 or 4 and R4 is OH, NH2, NHOH or C1-6-alkoxy; or a pharmaceutically acceptable salt th
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: April 10, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Rolf Hohlweg, Tine Krogh Jørgensen, Knud Erik Andersen, Uffe Bang Olsen, Zdenék Polivka, Karel Sindelar
  • Patent number: 6187770
    Abstract: The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula wherein X, Z, R1, R2 and r are as defined in the detailed part of the present description, or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation, as well as their use for treatment of indications caused by or related to the secretion and circulation of insulin antagonising peptides, e.g. non-insulin-dependent diabetes mellitus (NIDDM) and ageing-associated obesity.
    Type: Grant
    Filed: March 15, 1999
    Date of Patent: February 13, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Tine Krogh Jørgensen, Rolf Hohlweg, Knud Erik Andersen, Uffe Bang Olsen, Zdenék Polivka, Karel Sindelar